University Of Maryland, College Park

University Of Maryland, College Park operates as a federal prime recipient on research and education grants and as a subcontractor on clinical research and health services delivery programs, with recent work spanning vaccine development, deprescribing networks, data evaluation, and forest management. The institution holds no federal contract vehicles but functions as a prime grantee on awards from the National Institutes of Health and other health-focused agencies, and subcontracts under primes including Thomas Jefferson University, Northern California Institute For Research And Education, and Maryland state agencies. As an academic research institution, University Of Maryland does not hold SBA designations; its federal footprint is structured entirely through grant and sub-award mechanisms rather than competitive procurement set-asides.

The institution's customer base is concentrated in health and human services. The Department of Health and Human Services Substance Abuse and Mental Health Services Administration accounts for eight awards (44% of all recent awards), while the Department of Veterans Affairs Technology Acquisition Center Austin, the National Institutes of Health Office of the Director, the Smithsonian Institution, and the Environmental Protection Agency round out the active set. Dollar concentration diverges from award volume — the VA and NIH carry disproportionate potential value on single awards, but the bulk of recent activity flows through SAMHSA programming. The top five customers account for 44% of award count but only 28% of combined potential value, reflecting a portfolio of numerous small-dollar grants alongside fewer high-value awards.

Recent capability work demonstrates University Of Maryland's health research orientation. The institution serves as a sub-recipient under Thomas Jefferson University on a March 2025 Infectious Diseases Rapid Response Centers clinical trial evaluating a rabies-vectored monovalent Lassa fever vaccine in humans, with the Center for Vaccine Development and Global Health handling regulatory coordination, study sponsorship, protocol design, and clinical execution. University Of Maryland subcontracts under Northern California Institute For Research And Education on a July 2026 award to direct the Stakeholder Engagement Core of a deprescribing network, conducting council convening, co-designing stakeholder resources, and serving on steering committees. The institution also performs data evaluation and training analysis under Maryland Department of Health grants and supports forest management deliverables under USDA Forest Service funding routed through the Maryland Department of Natural Resources.

Activity is episodic rather than consistent — one award in 2010, one in 2013, then eight awards in 2024 and three in 2025 — suggesting recent ramping or a shift in data capture. Combined dollars obligated ($9.7 million) significantly exceed combined potential value ($2.2 million), indicating that the source captures either invoiced funds exceeding contract ceilings or multi-year awards with obligation patterns that cumulate above stated contract maximums. The institution's work is categorized predominantly under Educational Support Services and Internet Publishing and Broadcasting NAICS codes, with Professional Support and Communications-oriented PSC work dominating the classification profile. No recompete cliff is visible in the source data.